- Home
- AKAN vs QNRX Comparison
AKAN vs QNRX Comparison
Compare AKAN & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKAN
- QNRX
- Stock Information
- Founded
- AKAN 2021
- QNRX 2018
- Country
- AKAN United Kingdom
- QNRX United States
- Employees
- AKAN N/A
- QNRX N/A
- Industry
- AKAN Medicinal Chemicals and Botanical Products
- QNRX Medical/Dental Instruments
- Sector
- AKAN Health Care
- QNRX Health Care
- Exchange
- AKAN Nasdaq
- QNRX Nasdaq
- Market Cap
- AKAN 2.4M
- QNRX 2.5M
- IPO Year
- AKAN 2022
- QNRX N/A
- Fundamental
- Price
- AKAN $1.37
- QNRX $0.29
- Analyst Decision
- AKAN
- QNRX
- Analyst Count
- AKAN 0
- QNRX 0
- Target Price
- AKAN N/A
- QNRX N/A
- AVG Volume (30 Days)
- AKAN 22.5K
- QNRX 10.6M
- Earning Date
- AKAN 05-01-2025
- QNRX 03-13-2025
- Dividend Yield
- AKAN N/A
- QNRX N/A
- EPS Growth
- AKAN N/A
- QNRX N/A
- EPS
- AKAN N/A
- QNRX N/A
- Revenue
- AKAN $2,508,317.00
- QNRX N/A
- Revenue This Year
- AKAN N/A
- QNRX N/A
- Revenue Next Year
- AKAN N/A
- QNRX N/A
- P/E Ratio
- AKAN N/A
- QNRX N/A
- Revenue Growth
- AKAN N/A
- QNRX N/A
- 52 Week Low
- AKAN $1.22
- QNRX $0.21
- 52 Week High
- AKAN $47.52
- QNRX $1.57
- Technical
- Relative Strength Index (RSI)
- AKAN 34.11
- QNRX 49.51
- Support Level
- AKAN $1.32
- QNRX $0.21
- Resistance Level
- AKAN $1.55
- QNRX $0.32
- Average True Range (ATR)
- AKAN 0.07
- QNRX 0.03
- MACD
- AKAN -0.01
- QNRX -0.00
- Stochastic Oscillator
- AKAN 23.08
- QNRX 38.70
About AKAN Akanda Corp.
Akanda Corp is a cannabis cultivation, manufacturing, and distribution company. The Company has three reportable segments: Cultivation, Distribution, and Corporate. Cultivating activities comprise the cultivation segment made up of the medical cannabis cultivation operations at RPK/Holigen in Portugal, and medical cannabis cultivation activities. Distributing activities relate to the distribution of medical cannabis by Canmart Ltd in the United Kingdom. Corporate activities entail head office costs and other general corporate expenses related to the administration of the broader group.
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.